The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study).
about
Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue diseasePulmonary hypertension for primary care providersTherapy for pulmonary arterial hypertension associated with systemic sclerosis.Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary arterial hypertension associated with connective tissue diseasesVascular Complications of Systemic Sclerosis during Pregnancy.Serum endoglin levels in patients suffering from systemic sclerosis and elevated systolic pulmonary arterial pressureHow should we treat vascular and fibrotic lung disease in scleroderma?Treatment of pulmonary hypertension in patients with connective tissue disease and interstitial lung diseasePulmonary arterial hypertension associated with systemic sclerosis.Stress Doppler echocardiography for early detection of systemic sclerosis-associated pulmonary arterial hypertension.Regulation of Cell Cycle Regulators by SIRT1 Contributes to Resveratrol-Mediated Prevention of Pulmonary Arterial Hypertension.Pulmonary hypertension in parenchymal lung disease.Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment.Pulmonary arterial hypertension from a pediatric perspective.Prevalence of pulmonary arterial hypertension in patients with connective tissue diseases: a systematic review of the literature.Is early diagnosis of pulmonary arterial hypertension possible in inflammatory rheumatic diseases? Experience from a single center in Turkey.Changes in estimated right ventricular systolic pressure predict mortality and pulmonary hypertension in a cohort of scleroderma patients.Pulmonary blood volume indexed to lung volume is reduced in newly diagnosed systemic sclerosis compared to normals--a prospective clinical cardiovascular magnetic resonance study addressing pulmonary vascular changes.Quality indicator set for systemic sclerosis.Pulmonary arterial hypertension: the most devastating vascular complication of systemic sclerosis.Relationship of main pulmonary artery diameter to pulmonary arterial pressure in scleroderma patients with and without interstitial fibrosis.Evaluation of imatinib mesylate in the treatment of pulmonary arterial hypertension.Clinical associations with autoantibody reactivities to individual components of U1 small nuclear ribonucleoprotein.The short-term role of corticosteroid therapy for pulmonary arterial hypertension associated with connective tissue diseases: report of five cases and a literature review.Practical approach to screening for scleroderma-associated pulmonary arterial hypertension.Platelets in pulmonary hypertension: a causative role or a simple association?Pulmonary hypertension in rheumatic diseases: epidemiology and pathogenesis.Expert consensus for performing right heart catheterisation for suspected pulmonary arterial hypertension in systemic sclerosis: a Delphi consensus study with cluster analysis.Genomics and proteomics of pulmonary vascular disease.Current therapies for the treatment of systemic sclerosis-related pulmonary arterial hypertension: efficacy and safety.Clinical and laboratory profiles of 136 systemic sclerosis patients with and without echocardiographically detected pulmonary hypertension.Association of Anemic Hypoxia and Increased Pulmonary Artery Systolic Pressure in Patients With Systemic Lupus Erythematosus.Dyspnea assessment and pulmonary hypertension in patients with systemic sclerosis: utility of the University of California, San Diego, Shortness of Breath Questionnaire.Pulmonary arterial hypertension associated with systemic sclerosis in the Czech Republic.Opportunities and challenges in the study of pulmonary arterial hypertension.Prediction of pulmonary hypertension related to systemic sclerosis by an index based on simple clinical observations.Chinese SLE Treatment and Research group (CSTAR) registry: II. Prevalence and risk factors of pulmonary arterial hypertension in Chinese patients with systemic lupus erythematosus.Rapid progression to pulmonary arterial hypertension crisis associated with mixed connective tissue disease in an 11-year-old girl.High levels of uric acid in systemic lupus erythematosus is associated with pulmonary hypertension.Ultrasound signs of pulmonary fibrosis in systemic sclerosis as timely indicators for chest computed tomography.
P2860
Q24681558-0EF22719-20C1-4459-9F7A-9BA7C9256ECBQ33160056-7D4FD814-8B3B-4E8D-A6AA-2E3EFAFE6D95Q33805746-B845D6F4-98AF-46D8-A3AC-EA8AF35BA8B5Q33965825-0B0C7BDC-D125-42C2-B7A6-879D8DD446C7Q34097385-53B5F899-9AF6-42FC-937C-738898F7E23EQ34143652-1A81B576-7E02-4137-AEA9-15331333814BQ34167350-4F93381D-C694-41A4-B398-C1BFC7C34CBBQ34425493-06B96F4F-7771-408E-8286-2D64B6A96C50Q35002423-2ADAE796-3C61-46AB-ABC5-AA1CC6C64B97Q35857181-3A9DF3CF-B8C4-4AEC-8967-3A040EBDD49AQ35930978-7B899515-FB85-4AC0-9C38-8F6114ECE73FQ36328903-B5C2593A-9301-4E44-93BF-8115D779CDD9Q36839875-46FB60C6-0E2A-4027-BD00-6ACAA36B4327Q37084786-74226C0E-AAFE-48C1-B1CD-6B80365BCFD3Q37185564-487F3342-15E2-4111-A295-6D55A4E4B491Q37305115-379DA95A-A291-4DDA-A591-683CA0286F68Q37340271-7E57C845-9B67-49A1-BD5C-7195A3F60DD7Q37363859-BF58E92B-B4C0-40ED-9446-D57FBE5C90AEQ37460639-8C016D9C-8000-42C8-B934-1D90A8905631Q37504296-82044D15-43E0-41E4-9297-C4BF02EDBA9DQ37647966-4863F20F-2109-4FAB-AD19-F67D2029F8F8Q37656327-244AAE6E-1D80-44CA-8902-7CB559C8F683Q37656861-8D9DBA13-48A0-4FE1-9B19-DE3D26B342FDQ37890143-B5176D63-C6AE-4B1B-8392-6654290ED9FFQ37955130-EDEE7C99-7FC9-4050-BF33-B63995C2C447Q38051350-B9821F75-9066-4518-9537-BD096B551DBDQ38075430-CEE90212-2CA1-46A7-A358-32B9BCA59448Q38076680-1116A1DB-2B42-44BA-AD28-F220ABB85D43Q38112045-1BB8BED4-6D2E-4F34-A6D6-305014E243F8Q38175430-3FA01A7A-9129-4379-898B-A02F76505180Q38218044-95BACC17-2482-40CA-A8CF-5F7A46A316B1Q40896042-2CB206D2-9293-46A6-9856-2ED136903474Q43838317-1F47E20E-0270-4F06-A2BA-77212CFC3151Q43838385-4B9C81A7-3E3E-4017-9AD3-A5CF43507740Q44069499-31EE2740-87B7-49EA-9452-CCBA723948CEQ44262313-3EE421A5-1B4F-420E-A9FB-F0B2A6AECC6BQ44490545-CC21BFEF-A235-471C-AA54-F0C97987E55CQ44525680-47D7418D-CF81-4AAB-ADCE-BF268D8E4637Q44794385-AFB24161-315D-4295-A420-012DE3C798DDQ51619263-A89B03F0-1E03-4634-A5F6-4EB4CA87D699
P2860
The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study).
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
The prevalence of undiagnosed ...... tologists (the UNCOVER study).
@ast
The prevalence of undiagnosed ...... tologists (the UNCOVER study).
@en
type
label
The prevalence of undiagnosed ...... tologists (the UNCOVER study).
@ast
The prevalence of undiagnosed ...... tologists (the UNCOVER study).
@en
prefLabel
The prevalence of undiagnosed ...... tologists (the UNCOVER study).
@ast
The prevalence of undiagnosed ...... tologists (the UNCOVER study).
@en
P2093
P356
P1476
The prevalence of undiagnosed ...... tologists (the UNCOVER study).
@en
P2093
Clive Ward-Able
David McLain
Fredrick M Wigley
J Lincoln Chapin
Joao A C Lima
Maureen Mayes
P304
P356
10.1002/ART.21131
P577
2005-07-01T00:00:00Z